Research suggests that preserving klotho through histone deacetylase inhibition may help reduce bone injury associated with chronic kidney disease in mice. Studies have also explored the relationship between kidney health and bone density in humans, as well as the potential for therapeutic interventions to alleviate renal injury and fibrosis. The connection between klotho levels, bone mineral density, and kidney disease is being investigated in both animal models and human populations.